
Lazard US Equity Concentrated Portfolio
LEVIX
Updated: 23/09/2026, 00:27:11
The Lazard US Equity Concentrated Portfolio primarily allocates capital to common stocks of U.S.-based companies, spanning all market capitalizations. It maintains a highly focused investment approach, typically holding positions in a select group of 15 to 35 companies. These enterprises generally boast market capitalizations exceeding $350 million. Its investment objective is to achieve performance superior to recognized broad-based equity market benchmarks, such as the S&P 500®, Russell 1000®, and Russell 3000® Indices. During typical market environments, at least 80% of its total assets are committed to U.S. equity securities. Notably, this fund operates as a non-diversified investment vehicle.
No summaries found.
- Share price
- $14.59
- Market cap
- $1.43B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- N/A
- Employees
- N/A
- IPO date
- 03/10/2005
- Beta
- 1.19
- Last dividend
- $0.00
- Day range
- $14.59 – $14.59
- 52-week range
- $10.53 – $14.59
- 1-day performance
- 1.97%
- 1-year performance
- 38.57%
- Current drawdown (1Y)
- 0.00%
- CIK
- 0000874964
- CUSIP
- 52106N616
- ISIN
- US52106N6168
- Created
- 07/12/2025, 05:02:41
- Last update
- 23/09/2026, 00:27:11
Track Lazard US Equity Concentrated Portfolio with an AI analyst
See which prediction-market events move LEVIX, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.